Core Viewpoint - TerrAscend Corp. has officially launched TYSON 2.0 products in Pennsylvania and Maryland, marking a significant milestone in its partnership with Mike Tyson's cannabis brand [1][2]. Product Launch - The initial rollout includes premium flower and high-potency vapes, available at TerrAscend's Apothecarium dispensaries and through third-party wholesale partners [2]. - In Pennsylvania, the launch features 3.5g and 28g premium flower jars alongside live resin disposable vapes, while Maryland will debut 3.5g and 14g flower SKUs and distillate vapes, with more product formats expected throughout 2026 [5]. Executive Commentary - Mike Tyson expressed enthusiasm for the launch, emphasizing that the brand reflects his personal journey with cannabis and aims to provide quality and intensity to consumers [2]. - Jason Wild, Executive Chairman of TerrAscend, highlighted the importance of Tyson's energy and focus in the industry and the company's ability to leverage its cultivation and retail footprint for this expansion [2]. Company Overview - TerrAscend is a leading cannabis company listed on the TSX, with operations across North America, including Pennsylvania, New Jersey, Maryland, Ohio, and California [3]. - The company operates The Apothecarium and other retail locations, along with cultivation, processing, and manufacturing facilities, ensuring high-quality cannabis products for both medical and adult-use markets [3]. - TerrAscend owns or licenses several brands, including Cookies, Lemonnade, and Wana, enhancing its product offerings [3].

Core Viewpoint - Jushi Holdings Inc. has reached a settlement with Revelry Supply, Inc. to resolve litigation related to the sale of unregulated hemp-derived THC products in Pennsylvania, marking a significant step in the company's efforts to protect the integrity of state-regulated cannabis markets and public health [1][2][3][4]. Group 1: Settlement Agreement - The settlement agreement with Revelry is effective as of February 11, 2026, and is the first resolution in a broader enforcement action initiated by Jushi's subsidiaries against multiple entities [1][3]. - The litigation was part of a broader action against unregulated wholesalers and smoke shops selling illegal marijuana products disguised as "hemp," which undermines the regulated market and poses public health risks [2][4]. Group 2: Company Commitment - The company emphasizes its commitment to ensuring transparency, product testing, and regulatory accountability in the cannabis market, aiming to address the proliferation of under-regulated intoxicating products [4]. - Jushi will continue to pursue claims against remaining defendants in Pennsylvania and other states to uphold the integrity of the cannabis industry [4]. Group 3: Company Overview - Jushi Holdings Inc. is a vertically integrated, multi-state cannabis operator focused on building high-quality retail, cultivation, manufacturing, and distribution operations across various U.S. markets [5].

Core Insights - Shares of Green Thumb Industries (GTBIF) have been declining due to regulatory hurdles and increasing competition in the U.S. cannabis market, rather than company-specific issues [1][2][11] Company Performance - Green Thumb reported revenues of approximately $1.2 billion for the full year 2025, reflecting a year-over-year growth of 3.4%, driven by retail cannabis sales and expansion into new adult-use markets like Minnesota [5][11] - The company expanded its retail footprint by 12 locations, bringing the total store count to 113 nationwide [5] - Green Thumb generated $295 million in operating cash flow for the year, an increase of roughly $100 million year over year, indicating a strong operating model despite competitive pressures [6] Market Dynamics - The U.S. cannabis market is facing stiff competition, with pricing pressure and aggressive expansion strategies from competitors like Cresco Labs and Tilray Brands [9][12] - Green Thumb's reliance on the U.S. market exposes it to domestic regulatory uncertainties and pricing pressures in maturing markets, unlike competitors with international exposure [12] Future Outlook - The company is expected to face continued pressure from pricing compression in mature markets, with management anticipating first-quarter 2026 revenues to be down mid-single digits sequentially [8] - Analysts have lowered EPS estimates for 2026 and 2027, reflecting a cautious outlook and limited near-term earnings visibility [15][17]

Financial Data and Key Metrics Changes - SNDL achieved record full-year net revenue of CAD 946 million, representing a growth of 2.8% year-over-year, supported by 11% growth from combined cannabis segments, partially offset by a 2.8% decline in liquor [10] - Free cash flow for 2025 reached CAD 18 million, more than doubling the result from the previous year [3][11] - Gross profit for Q4 was CAD 70.2 million, marking a new quarterly record, with a gross margin increase of 110 basis points to 27.8% [9] Business Line Data and Key Metrics Changes - The cannabis retail segment achieved a full-year revenue record of CAD 330 million, representing a 6% growth, supported by same-store sales growth of 3.9% and new store openings [19] - The liquor segment experienced a 2% year-over-year decline in net revenue for Q4, but managed to maintain or expand gross profit through productivity improvements [13][17] - Cannabis operations delivered record net revenue of CAD 144.7 million for the full year, representing a growth of 32%, supported by the Indiva acquisition [20] Market Data and Key Metrics Changes - Both retail and operations segments gained market share despite a market slowdown in the second half of 2025 [4] - The liquor segment faced a consistent revenue decline of approximately 3% year-over-year, driven by broader market conditions [17][43] - The cannabis market experienced a slowdown in the second half of 2025, leading to a decline in the fourth quarter [12][30] Company Strategy and Development Direction - SNDL is focused on growth, profitability, and people, with plans to continue expanding its market share through new store openings and strategic acquisitions [22][24] - The company aims to leverage its strong balance sheet with no debt and over CAD 250 million in unrestricted cash for disciplined capital deployment [5] - SNDL is positioned to capitalize on industry consolidation opportunities as less efficient operators face increased pressure [12][34] Management's Comments on Operating Environment and Future Outlook - Management noted that the market is becoming saturated, particularly in retail, leading to declines in traffic and top-line revenue [30] - The company remains committed to sustaining its upward trajectory in profitability despite market headwinds [12] - Management expressed optimism about the potential for international growth and the completion of EU GMP certification by summer [39] Other Important Information - SNDL has repurchased a total of 15.1 million shares since Q4 2024, including 4.3 million shares in the last 90 days [7] - The company is finalizing the acquisition of Cost Cannabis retail stores, incorporating five locations in Alberta and Saskatchewan [5][32] Q&A Session Summary Question: What is behind the slowdown in the SNDL retail segment? - Management attributed the slowdown to market saturation, competitive pressures, and a shift in focus towards profitability and mix improvements [30] Question: When is the acquisition of 1CM Inc. stores expected to close? - Management expects to report back to shareholders on the timing in Q2, as they are finalizing their review with the AGCO [33] Question: How does SNDL view the liquor retail market outlook for 2026? - Management indicated that while there are structural challenges, certain areas within their portfolio, like the Wine and Beyond banner, are showing strength and growth [44] Question: What is the status of EU GMP certification and international growth outlook? - Management expects to complete the EU GMP certification by summer and anticipates material growth in international business, albeit from a small base [39] Question: What is the current status of the U.S. assets, particularly Parallel and Skymint? - Management noted that they are nearing resolution on the foreclosure process for Parallel and expect to finalize it in Q2 [50]

Core Insights - SNDL Inc. reported record financial performance for the full year 2025, with net revenue reaching CAD 946.4 million, a growth of 2.8% compared to the previous year, driven by strong growth in the Cannabis business [5][30] - The company achieved new records in gross profit and gross margin, with gross profit of CAD 258.6 million for the full year, reflecting a 7.6% increase year-over-year [5][30] - Positive cash flow was reported, with CAD 33.9 million for the full year, and free cash flow more than doubled from the previous year to CAD 18.0 million [5][30] Financial Performance - Net revenue for Q4 2025 was CAD 252.5 million, a decrease of 2.0% compared to Q4 2024, while full-year revenue was CAD 946.4 million [5][8] - Gross profit for Q4 2025 was CAD 70.2 million, up 2.1% year-over-year, and CAD 258.6 million for the full year, up 7.6% [5][30] - Operating income for Q4 2025 was CAD 11.8 million, a significant improvement from a loss of CAD 76.1 million in Q4 2024 [5][30] Business Segments - The Cannabis Retail segment achieved net revenue of CAD 330.2 million for the full year, a 6.0% increase from the previous year, while the Cannabis Operations segment reported a 32.1% increase in revenue to CAD 144.7 million [11][21] - Liquor Retail revenue declined by 2.8% for the full year to CAD 539.6 million, with same-store sales down 2.3% [15][16] - The company operates 192 cannabis retail locations and 167 liquor retail locations as of March 2026 [14][16] Strategic Initiatives - SNDL is advancing its restructuring efforts in the U.S. cannabis market, particularly with its investments in Parallel and Skymint [6][26] - The company has increased capital expenditures to CAD 12.8 million in 2025, focusing on new store openings [6] - SNDL has repurchased 4.3 million common shares since December 2025, totaling 15.1 million shares repurchased since Q4 2024 [12][26] Cash Position and Investments - As of December 31, 2025, SNDL had CAD 252.2 million in unrestricted cash and no debt, positioning the company for future growth opportunities [7][26] - The investment portfolio generated CAD 4.2 million in operating income for the full year, primarily from interest earned [26] - The company has a carrying value of CAD 397.6 million in cannabis-related investments, with ongoing restructuring processes for its investments in Skymint and Parallel [26]

Core Insights - Ascend Wellness Holdings, Inc. ("AWH") expects Q4 2025 revenue to be approximately $120 million and FY 2025 revenue to be around $500 million, with Adjusted EBITDA of about $30 million and $117 million respectively [1][2] - The company reported an Adjusted EBITDA margin of approximately 25% for Q4 2025 and 23% for FY 2025, indicating effective cost management and operational efficiency [2][3] - AWH maintains a strong balance sheet with $86 million in cash and no significant debt maturities until 2029, providing financial stability for future operations and expansion [1][3] Financial Performance - For Q4 2025, AWH anticipates net revenue of ~$120 million and Adjusted EBITDA of ~$30 million, reflecting a solid performance in the cannabis sector [2] - The full year 2025 is projected to yield net revenue of ~$500 million and Adjusted EBITDA of ~$117 million, showcasing growth in the company's financial metrics [2] - The company achieved an Adjusted EBITDA margin of ~25% in Q4 2025 and ~23% for FY 2025, demonstrating effective cost controls and a favorable product mix [2][3] Strategic Initiatives - AWH has expanded its retail footprint to 47 stores as part of its densification strategy, focusing on a customer-centric, consumer packaged goods (CPG) operating model [3] - The company has successfully increased its product and brand portfolio, leading to market share gains in its core markets [3] - AWH is pursuing a disciplined approach to its expansion pipeline and M&A initiatives, supported by its strong liquidity and operational platform [3] Legal and Compliance Matters - On February 5, 2026, AWH was notified of an arbitration award in favor of Green Thumb Industries, Inc. regarding a 2018 agreement, which the company disputes [3] - Despite the arbitration outcome, AWH asserts it has sufficient liquidity to continue operations and comply with loan covenants [3]

Core Viewpoint - The U.S. cannabis sector is evolving as 2026 begins, with multi-state operators positioned for long-term growth despite ongoing volatility creating both risks and opportunities. Investors are focusing on companies with scale and brand strength, specifically AYR Wellness, Curaleaf Holdings, and Verano Holdings [1]. AYR Wellness Inc. (AYRWF) - AYR Wellness is a vertically integrated cannabis operator with a growing national footprint, operating cultivation, manufacturing, and retail assets across several states. The company serves both medical and adult-use customers and emphasizes premium flower and derivative products [2]. - AYR has faced industry-wide challenges, with revenue growth slowing due to pricing pressure and competition. However, it continues to generate meaningful top-line sales, and gross margins remain stable compared to peers. Operating expenses are elevated, impacting profitability, but liquidity management remains a priority [4]. Curaleaf Holdings Inc. (CURLF) - Curaleaf is one of the largest cannabis companies in the U.S., with a broad footprint across many legalized states and dozens of dispensaries. The company serves both medical and adult-use consumers, offering a wide range of branded products [5][7]. - Financially, Curaleaf demonstrates relative strength with high revenue, although year-over-year growth has slowed. Gross margins remain competitive, and operating cash flow has improved, supporting balance sheet flexibility. Cost controls have helped protect margins, and international operations contribute to incremental growth [9]. Verano Holdings Corp. (VRNOF) - Verano Holdings operates dispensaries across multiple high-value states and has a strong retail focus. The company prioritizes disciplined expansion in markets with strong demand fundamentals and emphasizes premium branding and customer experience [10]. - Despite generating significant revenue, Verano faces profitability challenges due to pricing compression affecting margins. Elevated operating expenses and interest costs have led to persistent net losses, but cash reserves support near-term operations. Management is focused on improving efficiency and reducing long-term expenses [12]. Overall Market Outlook - As January 2026 unfolds, the U.S. cannabis market is in transition, with AYR Wellness, Curaleaf, and Verano each offering unique strengths and sizable retail footprints. Financial discipline is critical, and investors should closely monitor margins, cash flow, and balance sheets as market conditions may improve over time [14].

Core Insights - Red White & Bloom Brands Inc. has appointed Mr. Michael Di Brina as a director effective January 12, 2026, bringing extensive experience in financial services and business sectors [1][3] - Mr. Di Brina oversees a portfolio with approximately $1.1 billion in assets under management and has been recognized for his contributions to both business and community [2] - The company acknowledges the resignation of founding director Michael Marchese, who is leaving to pursue other business interests, and expresses gratitude for his leadership during a transformative period [3][4] Company Overview - Red White & Bloom Brands Inc. operates as a multi-state cannabis operator with a focus on premium brands in the United States, Canada, and select international markets [5] - The company is concentrating its investments in major U.S. markets, including California, Florida, and Michigan, alongside Canadian and international markets [5]

分组1 - The article discusses the potential opportunity to invest in cannabis stocks, specifically highlighting Cronos Group (CRON) as a Canadian operator experiencing significant volatility due to news of potential rescheduling [1] - Julian Lin, a financial analyst, focuses on identifying undervalued companies with secular growth, emphasizing the importance of strong balance sheets and management teams in sectors with long growth runways [1] - The investment strategy includes combining growth-oriented principles with strict valuation hurdles to enhance the margin of safety, providing exclusive access to high-conviction stock picks and comprehensive research reports [1]

Core Insights - SNDL Inc. reported strong financial results for Q3 2025, achieving record free cash flow and positive cumulative free cash flow for the first nine months of the year, indicating operational and profitability improvements [4][6][8] - The company maintains a strong balance sheet with no debt and $240.6 million in unrestricted cash, positioning it for growth and investment opportunities [5][6] Financial Performance - **Net Revenue**: In Q3 2025, net revenue was $244.2 million, a 3.1% increase from Q3 2024, driven by a 13.5% growth in the combined Cannabis business, partially offset by a decline in the Liquor retail segment [6][8][30] - **Gross Profit**: Gross profit reached $64.2 million, up 1.9% year-over-year, with a gross margin of 26.3%, reflecting a slight decrease of 0.3 percentage points [6][8][30] - **Operating Income**: The company reported an operating loss of $11.1 million, improved by 40.3% compared to the previous year, influenced by non-cash items and restructuring charges [6][8][30] - **Free Cash Flow**: Free cash flow hit a record $16.7 million, primarily due to a reduction in working capital, despite significant CAPEX investments [6][8][30] Business Segments - **Cannabis Retail**: Generated net revenue of $85.0 million, a 4.8% increase year-over-year, with operating income growing by 107.2% [18][21] - **Cannabis Operations**: Achieved a 49.5% increase in net revenue to $37.4 million, although it faced an operating loss due to inventory write-offs [20][27] - **Liquor Retail**: Experienced a decline in net revenue to $139.4 million, down 3.6% year-over-year, with same-store sales decreasing by 2.6% [15][16] Strategic Initiatives - The company is pursuing the acquisition of 32 cannabis retail stores from 1CM Inc. for $32.2 million, pending regulatory review [12] - SNDL is investing in organic growth with plans for five new Cannabis store openings and two new Wine & Beyond stores in Q4 2025 [12] - The company continues to restructure SunStream Bancorp Inc. to enhance shareholder exposure to medical cannabis markets [12][27] Investment Portfolio - As of September 30, 2025, SNDL's investment portfolio had a carrying value of $410.8 million, with a positive operating income of $1.5 million generated during the quarter [27] - The company realized a gain of $5.3 million from the partial sale of its equity position in High Tide Inc. [27]